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Background: The erythrocyte membrane lesion is a serious diabetic complication. A number of studies suggested
that n-3 fatty acid could reduce lipid peroxidation and elevate α- or γ-tocopherol contents in membrane of
erythrocytes. However, evidence regarding the protective effects of flaxseed oil, a natural product rich in n-3 fatty
acid, on lipid peroxidation, antioxidative capacity and membrane deformation of erythrocytes exposed to high
glucose is limited.
Methods: Human peripheral blood erythrocytes were isolated and treated with 50 mM glucose to mimic
hyperglycemia in the absence or presence of three different doses of flaxseed oil (50, 100 or 200 μM) in the culture
medium for 24 h. The malondialdehyde (MDA) and L-glutathione (GSH) were measured by HPLC and LC/MS
respectively. The phospholipids symmetry and membrane fatty acid composition of human erythrocytes were
detected by flow cytometry and gas chromatograph (GC). The morphology of human erythrocyte was illuminated
by ultra scanning electron microscopy.
Results: Flaxseed oil attenuated hyperglycemia-induced increase of MDA and decrease of GSH in human
erythrocytes. Human erythrocytes treated with flaxseed oil contained higher C22:5 and C22:6 than those in the
50 mM glucose control group, indicating that flaxseed oil could reduce lipid asymmetric distribution and
membrane perturbation. The ultra scanning electron microscopy and flow cytometer have also indicated that
flaxseed oil could protect the membrane of human erythrocytes from deformation at high glucose level.
Conclusion: The flaxseed oil supplementation may prevent lipid peroxidation and membrane dysfunction of
human erythrocytes in hyperglycemia.
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The α-linolenic acid (ALA), the n-3 polyunsaturated
fatty acid (PUFA) existed in vegetable oils such as flax-
seed oil, is an essential fatty acid for humans [1]. In the
human body, ALA can be converted into longer-chain
n-3 PUFA including eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) [2]. Previous studies* Correspondence: huangfh@oilcrops.cn; lgliu@mails.tjmu.edu.cn
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reproduction in any medium, provided the orindicated that dietary n-3 PUFA may possess protective
effects against cardiovascular disease (CVD) [3]. The
Greenland Eskimos and Japanese have a high dietary in-
take of long-chain n-3 PUFA from seafood and a low in-
cidence of CVD [3]. An earlier study found that n-3
PUFA diets reduced the sequelae of cerebral and myo-
cardial infarction in experimental animals [4]. In
addition, n-3 PUFA supplementation could increase the
α- and γ-tocopherol contents of the red blood cell mem-
branes and membrane fluidity [5].
Oxidative stress is considered as a common cause of
diabetes mellitus (DM) [6]. A number of studies found
that severe malformation and high lipid peroxidation ind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients [7,8]. At high blood glucose level, erythrocytes
could easily deform into acanthoid cells (acanthocytes)
which is difficult to flow through the blood vessels or
microvessels [7,8]. This kind of cellular deformation was
probably related to hyperglycemia, protein glycation,
sorbitol accumulation or dyslipidemia [8]. The hypergly-
cemia or dyslipidemia easily induce serious oxidative
stress that causes serious cellular dysfunction as well as
hematic and vascular complications in diabetic patients
[6-9]. Previous researches have illustrated that PUFA
could reduce cellular dysfunction or other complications
of DM. For instance, ALA supplements for 12 weeks ele-
vated EPA and DHA contents of erythrocyte in healthy
people [10,11]. Moreover, it has been observed in clinical
research that ALA remarkably reduced lipid peroxida-
tion in serum of type-1 diabetic patients [12]. Zeman et
al reported that the concentrations of conjugated dienes
in low-density lipoprotein (LDL) increased significantly
and the levels of triglycerides, total homocysteine and
microalbuminuria decreased significantly after diabetic
patients ingested n-3 PUFA (Omega-3 Forte, 3.6 g/day)
and received statin-fibrate treatment (Pravastatin 20 mg+
micronized Fenofibrate 200 mg/day) [13]. Nettleton et
al reported that fish oil supplementation (4 g/day) and
corn oil capsules supplementation (1 g oil and 13.4 mg
α-tocopherol in each capsules) both significantly
increased levels of LDL- malondialdehyde (MDA) ad-
duct in type-2 diabetic patients [14]. However, studies
regarding the effect of flaxseed oil on antioxidation and
protecting membrane of erythrocytes at high glucose
level are limited.
Therefore, this study aims to use human peripheral
blood erythrocytes to test the hypothesis that flaxseed
oil supplement can reduce oxidative stress and protect




Thiobarbituric-acid (TBA), L-glutathione reduced (GSH,
99%), L-glutathione oxidized (GSSG, 98%), trifluoroace-
tic acid, borontrifluoride (BF3) / methanol (MeOH) and
hexane were purchased from Sigma-Aldrich (St. Louis,
MO, U.S.A). Annexin V-FITC kit was brought from
Keygen biotech company (Nanjing, China).
Blood sample collection and preparation
Blood samples were collected from 96 healthy and non-
smoking volunteers (48 males aged 28.21 ± 3.11 years
old and 48 females aged 27.76 ± 2.94 years old). Periph-
eral blood samples were collected into tubes containing
ethylenediamine tetraacetic acid (EDTA). The volunteers
were recruited from the clinical department of HubeiProvincial Center for Disease Control and Prevention
(Wuhan, China). Informed consent was obtained from
each individual. All procedures were approved by the
Medical Ethics Committee of Tongji Medical College.
The EDTA-blood mixture was centrifuged at 350 × g for
10 min (5804R, Eppendorf AG, Hamburg, Germany).
The clear plasma and buffy coat layers were carefully
discarded. The erythrocyte suspension was washed with
cold sodium chloride solution (0.15 M).
Flaxseed oil preparation, human erythrocytes culture and
study design
Flaxseed oil was kindly provided by Oil Crops Research
Institute-Chinese Academy of Agricultural Science (The
fatty acid compositions of flaxseed oil demonstrated in
Additional file 1: Table S1). Preparations of stock solu-
tion of flaxseed oil and erythrocytes culture were carried
out following the protocol described in earlier studies
[14,15]. Briefly, flaxseed oil was dissolved in ethanol to
three concentrations (50, 100 and 200 μM) and Phos-
phate Buffered Saline (PBS) was used as culture media
(0.01 M, pH= 7.4). In certain experiments, the erythro-
cyte suspension (400 μL) was pre-incubated with three
concentrations of flaxseed oil for 4 h, and then the glu-
cose stock solution (50 mM) was added to cell suspen-
sion and incubated for 20 h. The PBS and 50 mM
glucose without flaxseed oil served as negative control
group and positive control group respectively. The con-
tents of the flasks were incubated in a shaking water
bath at 37°C. Percentage of hemolysis was less than 1%
in all incubations. The erythrocytes were washed twice
with a 1-to-10 dilution with NaCl (0.15 M) before bio-
chemical analysis. All incubations contained 10 μL peni-
cillin-streptomycin/ml cell suspension to vitiate any
microbial growth during the overnight incubations. The
working solution of penicillin-streptomycin contained
100 U/mL penicillin G and 100 μg/mL streptomycin in
buffer.
MDA assayed by high performance liquid
chromatography (HPLC)
MDA, a widely used indicator of lipid peroxidation, was
assessed by HPLC, based on a previous report with some
modifications [6,15]. For this purpose, erythrocytes
(0.4 mL) were suspended in PBS (0.8 mL). The butylated
hydroxytoluene (0.025 mL, 88 mg BHT/10 mL absolute
alcohol) and trichloroacetic acid (TBA, 0.5 mL, 30%)
were also added in cell suspension. Then, the tubes were
vibrated on vortex and incubated on ice for 2 h. After
incubation, the tubes were centrifuged at 334 × g for
15 min (5804R, Eppendorf AG, Hamburg, Germany).
For each sample, 1 mL supernatant was transferred to a
new tube and 0.25 mL 1% TBA in 0.05 N NaOH was
added. The tubes were then mixed and kept in a boiling
Table 1 The membrane fatty acid composition of erythrocytes (% of total FA)
50 μM flaxseed oil +
50 mM glucose
100 μM flaxseed oil +
50 mM glucose





C14:0 2.90 ± 0.3* 3.70 ± 0.5** 4.20 ± 0.7** 1.90 ± 0.2 6.80 ± 0.4##
(Myristic acid)
C16:0(Palmitic acid) 36.44 ± 1.8* 27.25 ± 2.9** 24.22 ± 1.9** 38.10 ± 2.7 19.70 ± 2.2##
C17:0 0.61 ± 0.1 0.62 ± 0.2 0.67 ± 0.1 0.62 ± 0.1 0.64 ± 0.2
(Internal standard)
C18:0 19.16 ± 3.0* 14.81 ± 3.0** 10. 44 ± 3.3** 21.30 ± 3.9 5.50 ± 1.7##
(Stearic acid)
C18:1 21.11 ± 2.2* 19.01 ± 4.1** 16.71 ± 2.9** 24.40 ± 2.4 14.40 ± 0.9##
(Vaccenic acid)
C18:2 2.20 ± 0.3* 4.90 ± 0.6** 6.30 ± 0.8** 1.40 ± 0.2 9.60 ± 0.5##
(Linoleic acid)
C22:0 0.97 ± 0.2* 1.29 ± 0.2** 2.00 ± 0.4** 0.90 ± 0.1 3.90 ± 0.3##
(Behenic acid)
C22:5 0.77 ± 0.2* 1.40 ± 0.3** 1.90 ± 0.3** 0.70 ± 0.1 2.80 ± 0.2##
(Docosapentaenoic acid)
C22:6 0.79 ± 0.1* 1.10 ± 0.1** 2.10 ± 0.1** 0.60 ± 0.1 3.20 ± 0.6##
(Docosadienoic acid)
RBC fatty acids 18.29 ± 1.4* 20.10 ± 2.2** 27.89 ± 2.7** 17.04 ± 2.5 32.33 ± 3.1##
total concentration
(pmol/mg Hb)
Note: Three concentrations of flax seed oil effect on fatty acid composition of membrane. *: P< 0.05, ** and ##: P< 0.01 are significantly different from 50 mM
glucose group (n = 24).
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complex was assessed by HPLC after its separation with
ion exclusion and a reverse-phase C-18 column
(5.0 mm×250 mm, Waters, Milford, MA, USA). The
UV/vis detector set at 532 nm. All data were collected
and analyzed by an Empower Workstation 2.0 (Waters,
Milford, MA, USA).
GSH and GSSG detected by liquid chromatography/mass
spectrometric assay (LC/MS)
GSH and GSSG contents were determined by liquid
chromatography/mass spectrometric assay (LC/MS)
based on a previous report [16]. After incubation, the
blood samples were immediately centrifuged at 600 × g
for 5 min (5804R, Eppendorf AG, Hamburg, Germany).
The packed erythrocytes were then washed twice with
equal volumes of ice-cold isotonic saline solution. The
packed erythrocytes samples (400 μL) were added in ice-
cold KCl solution (1.15%, 400 μL). The suspensions were
lysed by freezing and thawing three times to ensure
complete lysis. About 50 μL of the cell lysate was trans-
ferred to a 1.5 mL snap-cap conical-bottom centrifuge
vial. The glutathione ethyl ester (20 μL, 0.01 mg/mL) was
added to cell lysate that severed as an internal standard.
The 2-Nitrobenzoic acid (100 μL, 10 mM; Sigma, St.
Louis, MO, USA) was also added to cell lysate. MSanalysis employed positive ion electrospray ionization
(Agilent 6404, Santa Clara, CA, USA). The HPLC eluate
was introduced into the stainless-steel electrospray capil-
lary spray held at 2.3 kV. The source and detector vol-
tages were 20 and 655 V. The low- and high-mass
resolutions were set at 12.5 during analysis. Selected ion
monitoring (SIM) was set to simultaneously monitor the
ions with m/z of 505 and 613 (protonated molecular ions
of GSH and GSSG). The HPLC conditions employed a
Phenomenex C-18 column (5.0 mm×500 mm, 411 Ma-
drid Avenue, Torrance, CA, USA), mobile phase A
(aqueous solution with 0.1% (v/v) trifluoroacetic acid)
and mobile phase B (acetonitrile). At time zero, mobile
phase A was pumped isocratically for 2 min. Mobile
phase B was increased from 0% to 60% (from 2 min to
12 min) and held at 60% for an additional 2 min (all flow
rates: 0.6 mL/min). The injection volume was 20 μL. All
data were expressed as nmol/g hemoglobin (Hb) [16].
The effects on membrane of human erythrocytes
analyzed by flow cytometry
The effects of flaxseed oil on erythrocyte membrane
were assessed as described in a previous report with
some modifications [17]. After incubation, the cell sus-
pension (4 × 105) was washed twice with PBS. Then, the
samples were suspended by binding buffer (300 μL) in
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China) was added to cell suspension for cell labeling. The
samples were examined by FACSCalibur flow cytometer
(Becton-Dickinson, San Jose, CA, USA). The CellQUEST
software programs (Becton-Dickinson, San Jose, CA,
USA) were used for data analysis. Forward and sideward
scatter profiles were used to define the region of the intact
red cell population. The percentage of Annexin V-FITC
positive erythrocytes was determined from the fluores-
cence signal in excess of that obtained with respect to a
negative (unlabeled) control sample aliquot.
Deformity of morphology of human erythrocytes assayed
by ultra scanning electron microscopy (USEM)
The sample slides were prepared according to a previ-
ously method [18]. Three drops of blood cell suspension
(5 × 106) were directly dripped into phosphate buffer
(0.05 M, pH 7.2, containing 2% glutaraldehyde solution).
The test tube was gently inverted three times, and the
cell suspensions were fixed for 1 h. The erythrocytes
were settled by gravity. One drop (1 × 106 cells) from the
erythrocyte layer was dripped onto a piece of glass
(2 cm× 2 cm). Erythrocytes adhered onto the sections
that were dehydrated with 50%, 70%, 90%, and 100%
ethanol until dry. After dehydration, the slides were
coated with gold vapour (Eiko IB-3 Ion Coater, Tokyo,
Japan). All sections of photos were magnified from 5000
to 25000 by ultra scanning electron microscopy (USEM,
EDAX FEI QUANTA 200, Amsterdam, Holland).
Fatty acid compositions of human erythrocytes
membrane assayed by gas chromatography assay (GC)
Fatty acid compositions of erythrocytes membrane were
detected by gas chromatography assay (GC) [19]. After in-
cubation, the blood samples were washed three times by a
1-to-10 dilution with NaCl (0.15 M) before gas chroma-
tography assay. The NaCl mixtures were centrifuged at
1000× g for 10 min (4°C) and discarded supernatant
(5804R, Eppendorf AG, Hamburg, Germany). The cell
sample (200 μL) was added to distilled water (800 μL) and
centrifuged at 956× g for 10 min. The cell pellet, which
contained the phospholipid membranes, was washed with
distilled water (800 μL) and centrifuged again at 956× g
for 10 min. After the centrifugation, the supernatant was
discarded and the cell pellet was suspended by distilled
water (400 μL) and chloroform/methanol (3 mL, v/v, 1:1).
The mixture was shaken for 10 min. Chloroform layer was
transferred into another tube and solvent was removed by
nitrogen evaporation. The phospholipids were simultan-
eously hydrolyzed and methylated with another mixture
(toluene, 100 μL and BF3/MeOH, 500 μL) at heating block
(100°C) for 60 min. After cooling, distilled water (800 μL)
and hexane (800 μL) were added to mixture. The mixture
was shaken for 5 min and mixture was settled on ice for30 min. Hexane layer (upper layer) contained the methy-
lated fatty acids that was transferred to gas chromatog-
raphy vials and stored at −20°C until analysis. The
samples were separated on a silica capillary column
(30 m×0.25 mm, 0.25 μm, Durabond chemically bond,
DB-WAX, Agilent, CA, U.S.A) with a 6890 N network gas
chromatograph and a 7683B series injector (Agilent, CA,
USA). The Chemstaion Revision A.08.03 (Agilent, CA,
U.S.A) was used for quantification and identification of
peaks. The analytic conditions were used as follows: sample
was injected 2 μL, carrier gas was 1.2 mL/min (nitrogen), in-
jector temperature was set on 260°C, flame ionization
detection was set on 275°C, split ratio was 1:20, oven tem-
peratures were from 185°C to 245°C with a stepped
temperature program and run times were set on 57–60min.
Statistical analysis
All data were presented as mean ± S.D. One-way
ANOVA followed by the least significant difference point
test was used to identify significantly different groups.
P < 0.05 indicates significant differences among groups.
Results
Flaxseed oil decreased MDA concentration in human
erythrocytes at high glucose level
As displayed in Figure 1, the MDA level in PBS group
was about 20-fold significantly lower than positive con-
trol group (0.2 ± 0.01 MDA nmol/mL versus 4.16 ± 0.62
MDA nmol/mL, R2= 0.997, P < 0.01). Meantime, three
doses of flaxseed oil obviously inhibited MDA levels that
were about 1-fold, 1.5-fold and 2-fold lower than 50 mM
glucose group respectively (R2= 0.997, P < 0.01).
Flaxseed oil maintained GSH and reduced GSSG in human
erythrocytes at high glucose level
As illustrated in Figure 2, the GSH level in PBS group
was remarkably about 2.9-fold higher than positive con-
trol group (2416.25 ± 147.35 GSH nmol/g Hb versus
830.82 ± 96.76 GSH nmol/g Hb, R2 = 0.9985, P < 0.01).
The GSH levels in three flaxseed oil groups were about
1-fold, 2-fold and 2.5-fold higher than 50 mM glucose
group respectively. Furthermore, as demonstrated in
Figure 2 B, three doses of flaxseed oil significantly
inhibited GSSG levels that were about 1-fold, 2-fold
and 3-fold lower than positive control group respect-
ively (R2 = 0.9979, P < 0.01). The GSSG level in PBS
group was also 8.3-fold lower than positive control
group (21.67 ± 3.14 GSSG nmol/g Hb versus
181.74 ± 9.77 GSSG nmol/g Hb, R2 = 0.9979, P < 0.01).
Flaxseed oil maintained phospholipids symmetry of
membrane in human lymphocytes at high glucose level
The fluorescent labeling level in PBS group was about
12-fold lower than 50 mM glucose group (1.13 ± 0.17%
Figure 1 demonstrated flaxseed oil reduced MDA level in erythrocytes. The MDA level in three concentrations of flaxseed oil and
PBS groups were remarkably lower than 50 mM glucose group. The ## and ** indicate significant difference from 50 mM glucose group
(n = 24, P< 0.01).
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cent labeling levels in three flaxseed oil groups were
about 0.5-fold, 1-fold and 2-fold lower than 50 mM glu-
cose group respectively (P < 0.01). Besides, as demon-
strated in Figure 3 B1-B5 (representative images of flow
cytometer), the fluorescent labeling levels in three flax-
seed oil groups (Figure 3 B1-B3) and PBS group (Figure 3
B4) were obviously lower than 50 mM glucose group
(Figure 3 B5).
Flaxseed oil maintained normal cellular erythrocytes
profile in human erythrocytes at high glucose level
As illustrated in Figure 4 (representative images of
USEM). The Figure 4 A1 and B1 demonstrated that the
lowest dose of flaxseed oil (50 μM) exerted minor effects
on blood cells at high glucose level. Many bulges emerged
on membrane (red arrows). The 100 μM group (Figure 4
A2 and B2) and 200 μM group (Figure 4 A3 and B3) obvi-
ously inhibited membrane damage and deformation that
both were better than 50 μM flaxseed oil group and posi-
tive control group. The Figure 4 A4 illustrated that ery-
throcytes became to acanthocytes at the high glucose
level. However, compared with positive control group, the
human blood cells maintained normal shape in PBS group
(Figure 4 B4).
Flaxseed oil affected fatty acid composition of
membranes in human erythrocytes at high glucose level
Fatty acid compositions of membranes were summarized
in Table 1. In our results, the percentage of RBC C18:0
in negative control group was obviously lower than
50 mM glucose group (25.5 ± 1.7% versus 44.3 ± 3.9%,P < 0.01). The percentages of RBC C16:0, C18:0 and
C18:1 in the 50 μM flaxseed oil group were also lower
than positive control group respectively (P < 0.05). The
percentages of RBC C22:0, C22:5 and C22:6 were higher
than 50 mM glucose group (P < 0.05). Moreover, the per-
centages of RBC C16:0, C18:0 and C18:1 in 100 μM or
200 μM flaxseed oil groups were also remarkably lower
than 50 mM glucose group (P < 0.01). The percentages
of RBC C22:0, C22:5 and C22:6 also were significantly
higher than positive control group (P < 0.01). Meanwhile,
total concentration of membrane fatty acid in 50 μM
flaxseed oil group was higher than 50 mM glucose group
(18.29 ± 1.4 versus 17.04 ± 2.5 pmol/mg Hb, P < 0.05).
And total concentration of membrane fatty acid in
100 μM and 200 μM flaxseed oil groups were also obvi-
ously higher than 50 mM glucose group (20.10 ± 2.2 and
27.89 ± 2.7 versus 17.04 ± 2.5 pmol/mg Hb, P < 0.01).
Discussion
Hyperglycemia probably induce oxidative stress because
of excessive oxygen radical production caused by the
auto-oxidation of glucose or stimulation of cytochrome
P450-like activity, which results from excessive NADPH
production by glucose metabolism [6]. This study indi-
cated that flaxseed oil could reduce the lipid peroxida-
tion level (MDA) and GSSG, and maintain the GSH
contents in erythrocytes. In addition, Flaxseed oil could
also maintain the normal cellular shape in human
erythrocytes exposed to high glucose model.
MDA is an oxidative modification of cellular macro-
molecules, which can induce cell apoptosis, cell ne-
crosis, as well as tissue damage [18]. MDA molecules
Figure 2 A and B illuminated GSH and GSSG levels in erythrocytes. The Figure 2 A demonstrated that flaxseed oil maintained GSH levels in
erythrocytes. The GSH levels in three doses of flaxseed oil groups were obviously higher than 50 mM glucose group. The GSH level in PBS group
was also higher than 50 mM glucose group. In the Fig.2 B, flax seed oil remarkably reduced GSSG level in flaxseed oil groups, and PBS group was
also lower than 50 mM glucose group. The ## and ** indicate significant difference from 50 mM glucose group (n = 24, P< 0.01).
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phospholipids to form polymers. Thereby, these poly-
mers can induce abnormal morphology and malfunc-
tion of cells [18-20]. In the present study, flaxseed oil
reduced MDA level in human erythrocytes at high
glucose level. This phenomenon indicated that flax-
seed oil contained a high content of n-3 PUFA and
many double bonds in n-3 PUFA avoided damage on
membrane form oxidative stress [18]. Membrane in-
corporation of PUFAs may reduce cellular susceptibil-
ity to lipid peroxidation [19], alter membrane fluidity
[19], enhance receptor function, elevate enzyme activ-
ity [19,21] and influence the production of lipid med-
iators [19,21]. The observation was probably related to
the reaction of free radicals with methylene groups in
PUFA to avoid free radical conjugating with fatty
acids of membrane [7,22,23].GSH is the most abundant antioxidant in human body
[23,24]. As erythrocytes contain more than 95% of the
blood GSH [23,24], GSH plays a critical role for protect-
ing erythrocytes against oxidative stress [23-26]. A previ-
ous study observed that flaxseed oil could transfer
phenolic hydrogen to a peroxyl free radical of a peroxi-
dized PUFA [23]. This mechanism can inhibit the radical
chain reaction for preventing the peroxidation of PUFA
in cellular or subcellular membrane phospholipids [23].
Meanwhile, several studies in diabetic models also
showed that glucose could penetrate intracellularly to ac-
tivate polyol pathway and evoke depletion of NADPH
[23-29]. In this study, our results showed that flaxseed oil
reduced GSSG level and maintained GSH level in ery-
throcytes, suggesting it may enhance antioxidant capacity
in human erythrocytes. Similar findings were reported in
a previous study in erythrocytes of diabetic rats [30].
Figure 3 A and B illustrated erythrocytes were labeled by FITC probe. The Figure 3 A demonstrated that flaxseed oil protected membrane
of erythrocytes. The three concentrations of flaxseed oil groups and PBS group were obviously labeled by FITC less than 50 mM glucose group
(n = 24). The ## and ** indicate significant difference from 50 mM glucose group (P< 0.01). The Figure 3 B 1–5 were representative figures of flow
cytometry. The Figure 3 B 1–3 illustrated three concentrations of flaxseed oil protected on membrane. The PBS group (Figure 3 B 4) was also
significant difference from 50 mM glucose group (Figure 3 B 5).
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factors in the survival of cells during oxygen deprivation
[7,8]. Under hypoxia condition, change in the membrane
integrity is a symptom of injury. It can be measured aschanges in the lipid content and composition [8,11,]. In
many clinical researches, membrane perturbation can be
deemed as a result of oxidative stress [8,31-33]. were
related to phosphatidylserine (PS) externalization on
Figure 4 Representative erythrocyte images under scanning electron microscopy. In the Figure 4 A1 and B1, two figures demonstrated
that the lowest dose of flaxseed oil exerted minor ability on membrane. Many bulges gradually emerged on membrane (red arrows, 20000× and
25000×). In the Figure 4 A2 and B2, 100 μM flaxseed oil group was better than 50 μM flaxseed oil group, the membrane gradually became to
smooth and bulges also gradually alleviated on membrane (red arrows, 20000× and 25000×). In the Figure 4 A3 and B3 (20000× and 25000×),
the 200 μM flaxseed oil group was similar as PBS group (Figure 4 B4, 20000×), the normal shape and normal membrane in PBS group. In the
Figure 4 A4, the erythrocytes in positive group (50 mM glucose without flaxseed oil). The blood cells became flat cells (leptocyte) and acanthoid
cells (25000×). They basically lost their normal shape.
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High glucose exposure distorted erythrocytes to form
acanthocytes [8, 32 ,33, 34]. Thus, our results indicated
that flaxseed oil could counteract lipid peroxidation to en-
hance fluidity or prevent phosphatidylserine externalization
on membrane [32]. Meantime, images of ultra scanning
electron microscopy showed that flaxseed oil could main-
tain cellular shape of erythrocytes at high glucose level
and results of flow cytometry also illustrated similar
results. These results suggested that flaxseed oil could
maintain normal phospholipids symmetry on membrane
of erythrocytes [8,32-34].
The membrane of the red blood cell plays many roles
that aid in regulating their surface deformability, flexibility,
adhesion to other cells and immune recognition [35-37].
These functions are highly dependent on its composition,
which defines its properties [35]. Half of the membrane
mass in human and most mammalian erythrocytes are pro-
teins. The other half is lipids, namely phospholipids and
cholesterol [36]. The erythrocyte cell membrane comprises
a typical lipid bilayer, similar to what can be found in virtu-
ally all human cells [37]. This lipid bilayer is composed of
cholesterol and phospholipids in equal proportions by
weight. The lipid composition is important as it defines
many physical properties such as membrane permeability
and fluidity [37]. Unlike cholesterol which is evenly distrib-
uted between the inner and outer leaflets, the 5 major
phospholipids are asymmetrically disposed (outer mono-
layer: phosphatidylcholine, PC and sphingomyelin, SM;
inner monolayer: phosphatidylethanolamine, PE, phosphoi-
nositol, PI and phosphatidylserine, PS) [17,37,38]. In the
present study, concentrations of PUFA C18:2, C22:5 and
C22:6 were decreased in membrane while concentrations
of monounsaturated fatty acid (MUFA) C14:0 and C18:1
were dramatically increased, which resulted in a net higher
concentration of total monounsaturated fatty acids in the
positive control group [19,39]. Moreover, earlier studies
also found that the carbonyls of C18:1 and C16:0 were
exposed to the aqueous interface of phospholipids, the
C18:1 and C16:0 on membranes may result in increase of
rigid molecular order on membrane structures [19,39-42].
The worse partition of the fatty acid compositions in the
lipid bilayer may alter the biochemical properties of the cell
membrane, the membrane shape, organization, and perme-
ability [10,39,41-46]. Therefore, our results indicated that
flaxseed oil could protect against to the deformability of
human erythrocytes.Conclusion
Our study found that flaxseed oil could attenuate lipid
peroxidation, preserve anti-oxidation capacity and main-
tain fatty acid compositions of in membrane of human
erythrocytes. The flaxseed oil could also inhibitphosphatidylserine externalization of membrane. More
studies on detailed molecular mechanisms are warranted.
Additional file
Additional file 1: Table S1. Fatty acid compositions of flax seed oil.
Abbreviations
(PUFA), Polyunsaturated fatty acid; (ALA), α-linolenic acid;
(MeOH), Borontrifluoride (BF3) / methanol; (DHA), Docosahexaenoic acid;
(EPA), Eicosapentaenoic acid; (EDTA), Ethylenediamine tetraacetic acid;
(GC), Gas chromatography assay; (Hb), Hemoglobin (HPLC), High
performance liquid chromatography; (LDL), Low-density lipoprotein; (GSH),
L-glutathione reduced; (GSSG), L-glutathione oxidized; (LC/ MS), Liquid
chromatography/mass spectrometric assay; (MDA), Malondialdehyde;
(PC), Phosphatidylcholine; (PE), Phosphatidylethanolamine;
(PI), Phosphoinositol; (PS), Phosphatidylserine; (SM), Sphingomyelin;
(TBA), Thiobarbituric-acid; (USEM), Ultra scanning electron microscopy.
Competing interest
The authors declare that there is no conflict of interest.
Authors’ contributions
WY designed the experiments, analyzed the data and drafted the
manuscript. WY, JF, DW and MY operated all experiments. Qd H, Jq X and Qc
D prepared oil samples. All authors read and approve the final manuscript.
Acknowledgment
Funding
This study was supported by National Natural Science Foundation of China
(NSFC-31171681 and NSFC-30872116) and Modern Agro-industry Technology
Research System (CARS-17).
Author details
1Department of Nutrition and Food Hygiene, School of Public Health, Tongji
Medical College, Huazhong University of Science and Technology, 13
Hangkong Road, Wuhan 430030, China. 2Hubei Key Laboratory of Food
Nutrition and Safety, School of Public Health, Tongji Medical College,
Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan
430030, China. 3Oil Crops Research Institute, Chinese Academy of Agricultural
Science, 2-Xudong Road, Wuhan 430062, China.
Received: 10 February 2012 Accepted: 25 June 2012
Published: 8 July 2012
References
1. Goede J, Verschuren WM, Boer JM, Kromhout D, Geleijnse JM: α-linolenic
acid intake and 10-year incidence of coronary heart disease and stroke
in 20,000 middle-aged men and women in The Netherlands. PLoS One
2011, 6:365–369.
2. Allman MA, Pena MM, Pang D: Supplementation with flaxseed oil versus
sunflowerseed oil in healthy young men consuming a low fat diet: effects
on platelet composition and function. Eur J Clin Nutr 1995, 49:169–178.
3. Robertson TL, Kato H, Gordon T, Kagan A, Rhoads GG, Land CE, Worth RM,
Belsky JL, Dock DS, Miyanishi M, Kawamoto S: Epidemiologic studies of
coronary heart disease and stroke in Japanese men living in Japan,
Hawaii and California. Coronary heart disease risk factors in Japan and
Hawaii. Am J Cardiol 1977, 39:244–249.
4. Black KL, Culp B, Madison D, Randall OS, Lands WE: The protective effects
of dietary fish oil on focal cerebral infarction. Prostaglandins Med 1979,
3:257–268.
5. Siener R, Alteheld B, Terjung B, Junghans B, Bitterlich N, Stehle P, Metzner C:
Change in the fatty acid pattern of erythrocyte membrane
phospholipids after oral supplementation of specific fatty acids in
patients with gastrointestinal diseases. Eur J Clin Nutr 2010, 64:410–418.
6. Jain SK, Rains J, Jones K: Effect of curcumin on protein glycosylation, lipid
peroxidation, and oxygen radical generation in human red blood cells
exposed to high glucose levels. Free Radic Biol Med 2006, 41:92–96.
Yang et al. Lipids in Health and Disease 2012, 11:88 Page 10 of 10
http://www.lipidworld.com/content/11/1/887. Liu XB, Qin WH, Yin DZ: Biochemical relevance between oxidative/
carbonyl stress and elevated viscosity of erythrocyte suspensions.
Clin Hemorheol Micro 2004, 31:149–156.
8. Khera PK, Joiner CH, Carruthers A, Lindsell CJ, Smith EP, Franco RS, Holmes YR,
Cohen RM: Evidence for interindividual heterogeneity in the glucose
gradient across the human red blood cell membrane and its relationship
to hemoglobin glycation. Diabetes 2008, 57:2445–2452.
9. Kroger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Doring F, Joost HG,
Boeing H, Schulze MB: Erythrocyte membrane phospholipid fatty acids,
desaturase activity, and dietary fatty acids in relation to risk of type 2
diabetes in the European Prospective Investigation into Cancer and
Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011, 93:127–142.
10. Barcelo-Coblijn G, Murphy EJ, Othman R, Moghadasian MH, Kashour T, Friel JK:
Flaxseed oil and fish-oil capsule consumption alters human red blood cell
n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of
n-3 fatty acid. Am J Clin Nutr 2008, 88:801–809.
11. Legrand P, Schmitt B, Mourot J, Catheline D, Chesneau G, Mireaux M,
Kerhoas N, Weill P: The consumption of food products from linseed-fed
animals maintains erythrocyte omega-3 fatty acids in obese humans.
Lipids 2010, 45:11–19.
12. Tilvis RS, Helve E, Miettinen TA: Improvement of diabetic control by
continuous subcutaneous insulin infusion therapy changes fatty acid
composition of serum lipids and erythrocytes in type 1
(insulin-dependent) diabetes. Diabetologia 1986, 29:690–694.
13. Zeman M, Zak A, Vecka M, Tvrzicka E, Pisarikova A, Stankova B: N-3 fatty
acid supplementation decreases plasma homocysteine in diabetic
dyslipidemia treated with statin-fibrate combination. J Nutr Biochem 2006,
17:379–384.
14. Nettleton JA, Katz R: n-3 long-chain polyunsaturated fatty acids in type 2
diabetes: a review. J Am Diet Assoc 2005, 105:428–440.
15. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular
complications. Diabetes Care 1996, 19:257–267.
16. Xiang MG, Brianna H, Chandradhar D, Duane PM: A simultaneous liquid
chromatography/mass spectrometric assay of glutathione, cysteine,
homocysteine and their disulfides in biological samples. J Pharmaceut
Biomed 2003, 31:251–261.
17. Lopez RA, Sanchez JI, Garcia AC, Hernandez HA, Sanchez YJ, Llanillo M:
Membrane cholesterol in the regulation of aminophospholipid
asymmetry and phagocytosis in oxidized erythrocytes. Free Radic Biol
Med 2007, 42:1106–1118.
18. Ross SR, Lexin W, Herbert J: Erythrocyte Oxidative Damage in Chronic
Fatigue Syndrome. Arch Med Res 2007, 38:94–98.
19. Best CA, Cluette-Brown JE, Teruya M, Teruya A, Laposata M: Red blood cell
fatty acid ethyl esters: a significant component of fatty acid ethyl esters
in the blood. J Lipid Res 2003, 44:612–620.
20. Patricia LU, Mònica B, Patricia CA, Nancy B, Jordi SS: Nuts and oxidation:
a systematic review. Nutr Rev 2009, 67:497–508.
21. Wu D, Meydani SN: n-3 polyunsaturated fatty acids and immune
function. Proc Nutr Soc 1998, 57:503–509.
22. Alan A, Hennessy R, Paul R, Rosaleen D, Catherine S: The Health Promoting
Properties of the Conjugated Isomers of α-Linolenic Acid. Lipids 2011,
46:105–119.
23. Fang YZ, Yang S, Wu G: Free radicals, antioxidants, and nutrition.
Nutrition 2002, 18:872–879.
24. Constantin A, Constantinescu E, Dumitrescu M, Calin A, Popov D: Effects of
ageing on carbonyl stress and antioxidant defense in RBCs of obese
Type 2 diabetic patients. J Cell Mol Med 2005, 9:683–691.
25. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, Smieja M,
Cambien F, Meyer J, Lackner KJ: Glutathione peroxidase 1 activity and
cardiovascular events in patients with coronary artery disease. N Engl J Med
2003, 349:1605–1613.
26. Travis SF, Morrison AD, Clements RS Jr: Winegrad AI, Oski FA: Metabolic
alterations in the human erythrocyte produced by increases in glucose
concentration. The role of the polyol pathway. J Clin Invest 1971,
50:2104–2112.
27. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI: The central role of
glutathione in the pathophysiology of human diseases. Arch Physiol
Biochem 2007, 113:234–258.
28. Blanco RA, Ziegler TR, Carlson BA, Cheng PY, Park Y, Cotsonis GA, Accardi CJ,
Jones DP: Diurnal variation in glutathione and cysteine redox states in
human plasma. Am J Clin Nutr 2007, 86:1016–1023.29. Dominguez C, Ruiz E, Gussinye M, Carrascosa A: Oxidative stress at onset
and in early stages of type 1 diabetes in children and adolescents.
Diabetes Care 1998, 21:1736–1742.
30. Yilmaz O, Ozkan Y, Yildirim M, Ozturk AI, Ersan Y: Effects of alpha lipoic
acid, ascorbic acid-6-palmitate, and fish oil on the glutathione,
malonaldehyde, and fatty acids levels in erythrocytes of streptozotocin
induced diabetic male rats. J Cell Biochem 2002, 86:530–539.
31. Yao J, Stanley JA, Reddy RD, Keshavan MS, Pettegrew JW: Correlations
between peripheral polyunsaturated fatty acid content and in vivo
membrane phospholipid metabolites. Biol Psychiatry 2002, 52:823–830.
32. Williamson JR, Gardner RA, Boylan CW, Carroll GL, Chang K, Marvel JS,
Gonen B, Kilo C, Tran-Son-Tay R, Sutera SP: Microrheologic investigation of
erythrocyte deformability in diabetes mellitus. Blood 1985, 65:283–288.
33. Crosby NM: The role of oxidation in hyperglycemia-mediated erythrocyte
phospholipid asymmetry.: Indiana University, Molecular, Cellular, and
Developmental Biology; 2005. PhD thesis.
34. Helmut S, Wilhelm S, Alex S: Nutritional, Dietary and Postprandial
Oxidative Stress. J Nutr 2005, 135:969–972.
35. Tse WT, Lux SE: Red blood cell membrane disorders. Br J Haematol 1999,
104:2–13.
36. Mohandas N, Gallagher PG: Red cell membrane: past, present, and future.
Blood 2008, 112:3939–48.
37. Singer SJ, Nicolson GL: The fluid mosaic model of the structure of cell
membranes. Science 1972, 175:720–31.
38. Kume A, Miyazaki T, Kitamura Y, Oshida K, Yanagisawab N, Takizawa H, Fujii K,
Kiyanagi T, Sumiyoshi K, Ohmura H, Mokuno H, Shimada K, Daida H: High
levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in
whole blood are associated with metabolic syndrome in Japanese men.
Diabetes Res Clin Pract 2008, 80:259–264.
39. Yvonne V: Yuan, David DK: Dietary fat source and cholesterol interactions
alter plasma lipids and tissue susceptibility to oxidation in
spontaneously hypertensive (SHR) and normotensive Wistar Kyoto (WKY)
rats. Mol Cell Biochem 2002, 232:33–47.
40. Verkleij AJ, Zwaal RF, Roelofsen B, Comfurius P, Kastelijn D, van Deenen LL:
The asymmetric distribution of phospholipids in the human red cell
membrane. A combined study using phospholipases and freeze-etch
electron microscopy. Biochim Biophys Acta 1973, 323:178–193.
41. Ferrell JE Jr, Lee KJ, Huestis WH: Membrane bilayer balance and erythrocyte
shape: a quantitative assessment. Biochemistry 1985, 24:2849–2857.
42. Sylvie CB, Jésus G, Anne G, Brigitte P, Jean F, Sylvie A, Nathalie Ma, Pascal H,
Robert S, Marc B: Positive impact of long-term lifestyle change on
erythrocyte fatty acid profile after acute coronary syndromes.
Arch Cardiovas Dis 2010, 103:106–114.
43. McBride JA, Jacob HS: Abnormal kinetics of red cell membrane
cholesterol in acanthocytes: studies in genetic and experimental
abetalipoproteinemia and in spur cell anemia. Br J Haematol 1970,
18:383–396.
44. Anke J, Peter M, Eckard HC, Gerhard J: Trans-10, cis-12-CLA-caused
lipodystrophy is associated with profound changes of fatty acid profiles
of liver, white adipose tissue and erythrocytes in mice: possible link to
tissue-specific alterations of fatty acid desaturation. Ann Nutr Metab 2010,
57:103–111.
45. Bird D, Laposata M, Hamilton JA: Binding of ethyl oleate to low density
lipoprotein, phospholipid vesicles, and albumin: a 13 C NMR study.
J. Lipid Res 1996, 37:1449–1458.
46. Neubronner J, Schuchardt JP, Kressel G, Merkel M, Schacky CV, Hahn A:
Enhanced increase of omega-3 index in response to long-term n-3 fatty
acid supplementation from triacylglycerides versus ethyl esters.
Eur J Clin Nutr 2011, 65:247–254.
doi:10.1186/1476-511X-11-88
Cite this article as: Yang et al.: Effects of flaxseed oil on anti-oxidative
system and membrane deformation of human peripheral blood
erythrocytes in high glucose level. Lipids in Health and Disease 2012 11:88.
